United States Molecular Diagnostics in Cancer Testing Market Report 2017

February 2017 | 122 pages | ID: U43B023B35CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Molecular Diagnostics in Cancer Testing

Revenue, means the sales value of Molecular Diagnostics in Cancer Testing

This report studies sales (consumption) of Molecular Diagnostics in Cancer Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott Molecular Diagnostics
• Accugenomics
• Agendia
• Ambry Genetics
• Biodesix
• bioMerieux
• bioTheranostics (AviaraDx)
• Cancer Genetics
• Clarient, Inc. (GE Healthcare)
• Counsyl
• Flatiron Health
• Epigenomics
• Exact Sciences Corporation
• Exiqon
• Genomic Health
• Genoptix (Novartis)
• Genmark Diagnostics
• Genomictree
• HTG Molecular Diagnostics
• Invitae
• LabCorp
• Myriad Genetics
• Nanostring
• Neogenomics
• NSTG
• Nuvera Biosciences
• Orion Genomics
• Pathway Genomics

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Molecular Diagnostics in Cancer Testing in each application, can be divided into

• Application 1
• Application 2

Contents

United States Molecular Diagnostics in Cancer Testing Market Report 2017

1 MOLECULAR DIAGNOSTICS IN CANCER TESTING OVERVIEW

1.1 Product Overview and Scope of Molecular Diagnostics in Cancer Testing
1.2 Classification of Molecular Diagnostics in Cancer Testing
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Molecular Diagnostics in Cancer Testing
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Molecular Diagnostics in Cancer Testing (2012-2022)
  1.4.1 United States Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2022)
  1.4.2 United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

2 UNITED STATES MOLECULAR DIAGNOSTICS IN CANCER TESTING COMPETITION BY MANUFACTURERS

2.1 United States Molecular Diagnostics in Cancer Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Molecular Diagnostics in Cancer Testing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Molecular Diagnostics in Cancer Testing Average Price by Manufactures (2015 and 2016)
2.4 Molecular Diagnostics in Cancer Testing Market Competitive Situation and Trends
  2.4.1 Molecular Diagnostics in Cancer Testing Market Concentration Rate
  2.4.2 Molecular Diagnostics in Cancer Testing Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MOLECULAR DIAGNOSTICS IN CANCER TESTING SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by States (2012-2017)
3.2 United States Molecular Diagnostics in Cancer Testing Revenue and Market Share by States (2012-2017)
3.3 United States Molecular Diagnostics in Cancer Testing Price by States (2012-2017)

4 UNITED STATES MOLECULAR DIAGNOSTICS IN CANCER TESTING SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Type (2012-2017)
4.2 United States Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)
4.3 United States Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)
4.4 United States Molecular Diagnostics in Cancer Testing Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MOLECULAR DIAGNOSTICS IN CANCER TESTING SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Application (2012-2017)
5.2 United States Molecular Diagnostics in Cancer Testing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MOLECULAR DIAGNOSTICS IN CANCER TESTING MANUFACTURERS PROFILES/ANALYSIS

6.1 Abbott Molecular Diagnostics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Accugenomics
  6.2.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Agendia
  6.3.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Agendia Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Ambry Genetics
  6.4.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biodesix
  6.5.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biodesix Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 bioMerieux
  6.6.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 bioTheranostics (AviaraDx)
  6.7.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cancer Genetics
  6.8.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Clarient, Inc. (GE Healthcare)
  6.9.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Counsyl
  6.10.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Counsyl Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Flatiron Health
6.12 Epigenomics
6.13 Exact Sciences Corporation
6.14 Exiqon
6.15 Genomic Health
6.16 Genoptix (Novartis)
6.17 Genmark Diagnostics
6.18 Genomictree
6.19 HTG Molecular Diagnostics
6.20 Invitae
6.21 LabCorp
6.22 Myriad Genetics
6.23 Nanostring
6.24 Neogenomics
6.25 NSTG
6.26 Nuvera Biosciences
6.27 Orion Genomics
6.28 Pathway Genomics

7 MOLECULAR DIAGNOSTICS IN CANCER TESTING MANUFACTURING COST ANALYSIS

7.1 Molecular Diagnostics in Cancer Testing Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MOLECULAR DIAGNOSTICS IN CANCER TESTING MARKET FORECAST (2017-2022)

11.1 United States Molecular Diagnostics in Cancer Testing Sales, Revenue Forecast (2017-2022)
11.2 United States Molecular Diagnostics in Cancer Testing Sales Forecast by Type (2017-2022)
11.3 United States Molecular Diagnostics in Cancer Testing Sales Forecast by Application (2017-2022)
11.4 Molecular Diagnostics in Cancer Testing Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Molecular Diagnostics in Cancer Testing
Table Classification of Molecular Diagnostics in Cancer Testing
Figure United States Sales Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
Table Application of Molecular Diagnostics in Cancer Testing
Figure United States Sales Market Share of Molecular Diagnostics in Cancer Testing by Application in 2015
Figure United States Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2022)
Figure United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)
Table United States Molecular Diagnostics in Cancer Testing Sales of Key Manufacturers (2015 and 2016)
Table United States Molecular Diagnostics in Cancer Testing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Molecular Diagnostics in Cancer Testing Sales Share by Manufacturers
Figure 2016 Molecular Diagnostics in Cancer Testing Sales Share by Manufacturers
Table United States Molecular Diagnostics in Cancer Testing Revenue by Manufacturers (2015 and 2016)
Table United States Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers
Table 2016 United States Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers
Table United States Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers in 2015
Figure Molecular Diagnostics in Cancer Testing Market Share of Top 3 Manufacturers
Figure Molecular Diagnostics in Cancer Testing Market Share of Top 5 Manufacturers
Table United States Molecular Diagnostics in Cancer Testing Sales by States (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Sales Share by States (2012-2017)
Figure United States Molecular Diagnostics in Cancer Testing Sales Market Share by States in 2015
Table United States Molecular Diagnostics in Cancer Testing Revenue and Market Share by States (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Revenue Share by States (2012-2017)
Figure Revenue Market Share of Molecular Diagnostics in Cancer Testing by States (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Price by States (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Sales Share by Type (2012-2017)
Figure United States Molecular Diagnostics in Cancer Testing Sales Market Share by Type in 2015
Table United States Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)
Figure United States Molecular Diagnostics in Cancer Testing Sales Growth Rate by Type (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)
Table United States Molecular Diagnostics in Cancer Testing Sales Market Share by Application (2012-2017)
Figure United States Molecular Diagnostics in Cancer Testing Sales Market Share by Application in 2015
Table United States Molecular Diagnostics in Cancer Testing Sales Growth Rate by Application (2012-2017)
Figure United States Molecular Diagnostics in Cancer Testing Sales Growth Rate by Application (2012-2017)
Table Abbott Molecular Diagnostics Basic Information List
Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Accugenomics Basic Information List
Table Accugenomics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Accugenomics Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Agendia Basic Information List
Table Agendia Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Agendia Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Ambry Genetics Basic Information List
Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Biodesix Basic Information List
Table Biodesix Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biodesix Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table bioMerieux Basic Information List
Table bioMerieux Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table bioMerieux Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table bioTheranostics (AviaraDx) Basic Information List
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Cancer Genetics Basic Information List
Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Clarient, Inc. (GE Healthcare) Basic Information List
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Counsyl Basic Information List
Table Counsyl Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Counsyl Molecular Diagnostics in Cancer Testing Sales Market Share (2012-2017)
Table Flatiron Health Basic Information List
Table Epigenomics Basic Information List
Table Exact Sciences Corporation Basic Information List
Table Exiqon Basic Information List
Table Genomic Health Basic Information List
Table Genoptix (Novartis) Basic Information List
Table Genmark Diagnostics Basic Information List
Table Genomictree Basic Information List
Table HTG Molecular Diagnostics Basic Information List
Table Invitae Basic Information List
Table LabCorp Basic Information List
Table Myriad Genetics Basic Information List
Table Nanostring Basic Information List
Table Neogenomics Basic Information List
Table NSTG Basic Information List
Table Nuvera Biosciences Basic Information List
Table Orion Genomics Basic Information List
Table Pathway Genomics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Molecular Diagnostics in Cancer Testing
Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
Figure Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
Table Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
Table Major Buyers of Molecular Diagnostics in Cancer Testing
Table Distributors/Traders List
Figure United States Molecular Diagnostics in Cancer Testing Production and Growth Rate Forecast (2017-2022)
Figure United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)
Table United States Molecular Diagnostics in Cancer Testing Production Forecast by Type (2017-2022)
Table United States Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)
Table United States Molecular Diagnostics in Cancer Testing Sales Forecast by States (2017-2022)
Table United States Molecular Diagnostics in Cancer Testing Sales Share Forecast by States (2017-2022)